• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Wheel Integrates with GoodRx for Real-Time Medication Pricing & Discounts

Share:

December 18, 2021

Wheel, the digital health company putting great care within everyone’s reach, today announced a new integration with GoodRx, America’s digital resource for healthcare, to help people save on their prescription costs and follow their treatment plans. Now Wheel clients and their millions of patients can seamlessly access discounts on medications at more than 70,000 pharmacies nationwide.

One-third of US residents have trouble paying their medical bills and turn to their physicians for help navigating the costs and insurance coverage. However, a recent survey from JAMA Network shows that few physicians are able to accurately estimate out-of-pocket costs

GoodRx Integration

Through this integration, Wheel and GoodRx are providing clinicians with greater confidence that their patients will be able to start and stay on their medication. GoodRx’s coupon price API processes over 200 billion pricing data points every day to provide consumers with access to lower prices on their medication.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Through this integration, once a clinician prescribes a treatment plan, companies built on Wheel’s white-labeled virtual care platform will be able to seamlessly offer their patients a GoodRx coupon for their medication at their preferred pharmacy. Wheel’s virtual care platform and nationwide clinician network make it easy for companies to build telehealth services — whether they’re looking to scale nationwide, expand their treatment areas, offer 24/7 care coverage, or now provide direct cost savings to their patients.

“We’re excited to partner with GoodRx and make it easier and less expensive for people to follow their treatment plans,” said Wheel CEO and founder Michelle Davey. “Our goal is to provide companies with all the tools they need to build a great virtual care service for their patients. This partnership is another example of how we’re driving down the cost of care and improving health outcomes at scale.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Arine, Gemini Health Partner to Optimize Medications While Lowering Prescription Drug CostsArine, Gemini Health Partner to Optimize Medications While Lowering Prescription Drug Costs
  • Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in RevenueSunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue
  • Digital’s Potential in Clinical Trials, Medical AdherenceDigital’s Potential in Clinical Trials, Medical Adherence
  • Cultivate(MD) Capital Funds Announces Portfolio Company Embody’s Acquisition by Zimmer Biomet Holdings, Inc.Cultivate(MD) Capital Funds Announces Portfolio Company Embody’s Acquisition by Zimmer Biomet Holdings, Inc.
  • Foundation Health | Revolutionizing Healthcare Experiences with InnovationFoundation Health | Revolutionizing Healthcare Experiences with Innovation
  • US Hospital EMR Market Share Growth Driven by Small HospitalsUS Hospital EMR Market Share Growth Driven by Small Hospitals
  • Corrona Acquires Healthivibe, Expanding Its Presence in Patient ExperienceCorrona Acquires Healthivibe, Expanding Its Presence in Patient Experience
  • Sensei Biotherapeutics Completes Acquisition of Alvaxa Biosciences, a Camelid Antibody Therapeutics CompanySensei Biotherapeutics Completes Acquisition of Alvaxa Biosciences, a Camelid Antibody Therapeutics Company

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications